Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
- 1 December 2018
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 16 (12), 1964-1973.e1
- https://doi.org/10.1016/j.cgh.2018.04.033
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer centerBMC Cancer, 2013
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted TherapyMedicine, 2011
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapyAnnals Of The Rheumatic Diseases, 2011
- Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohortsThe Esophagus, 2011
- Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyGut, 2010
- Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infectionLiver International, 2010
- Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activityRheumatology, 2009
- Reactivation of hepatitis BJournal of Hepatology, 2009
- Review article: the use of potentially hepatotoxic drugs in patients with liver diseaseAlimentary Pharmacology & Therapeutics, 2008
- Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisGut, 2004